SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Jun-23 | Payment of Exercise | 22,605 | $38.53 | $870,971.00 | (37%) 60.32K to 37.71K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Jun-23 | Option Exercise | 54,318 | $16.03 | $870,856.00 | 905% 6.0K to 60.32K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Jun-23 | Option Sale | 31,713 | $38.82 | $1,231,250.00 | (84%) 37.71K to 6.0K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 31-May-23 | Payment of Exercise | 29,309 | $38.37 | $1,124,590.00 | (30%) 97.83K to 68.53K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 31-May-23 | Option Exercise | 79,835 | $14.80 | $1,181,870.00 | 444% 18.0K to 97.83K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 31-May-23 | Option Sale | 59,318 | $38.70 | $2,295,890.00 | (87%) 68.53K to 9.21K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 31-May-23 | Sale | 3,208 | $38.70 | $124,165.00 | (35%) 9.21K to 6.0K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 30-May-23 | Private Option Sale | 29,835 | $39.28 | $1,171,980.00 | (54%) 55.01K to 25.17K | |
01-Jun-23 7:25 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 30-May-23 | Sale | 7,171 | $39.28 | $281,692.00 | (28%) 25.17K to 18.0K | |
09-Mar-23 6:21 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-23 | Payment of Exercise | 3,778 | $37.13 | $140,277.00 | (5%) 78.02K to 74.24K | |
09-Mar-23 6:21 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-23 | Option Exercise | 72,016 | $2.64 | $190,225.00 | 1200% 6.0K to 78.02K | |
09-Mar-23 6:21 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-23 | Option Sale | 19,232 | $36.98 | $711,199.00 | (26%) 74.24K to 55.01K | |
16-Aug-22 5:31 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 16-Aug-22 | Sale | 52,058 | $38.51 | $2,004,900.00 | (90%) 58.06K to 6.0K | |
16-Aug-22 5:31 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Aug-22 | Sale | 33,942 | $37.76 | $1,281,650.00 | (37%) 92.0K to 58.06K | |
16-Aug-22 5:31 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Aug-22 | Private Sale | 91,135 | $38.28 | $3,488,600.00 | (50%) 183.13K to 92.0K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 08-Mar-22 | Sale | 14,551 | $25.82 | $375,636.00 | (7%) 197.69K to 183.13K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Payment of Exercise | 1,990 | $30.23 | $60,157.70 | (< 1%) 230.76K to 228.77K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Option Exercise | 20,576 | $3.67 | $75,513.90 | 10% 210.19K to 230.76K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Option Sale | 21,539 | $30.50 | $657,034.00 | (9%) 228.77K to 207.23K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 07-Mar-22 | Sale | 9,547 | $30.50 | $291,226.00 | (5%) 207.23K to 197.69K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Payment of Exercise | 963 | $31.42 | $30,257.50 | (< 1%) 220.47K to 219.51K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Option Exercise | 10,288 | $3.67 | $37,757.00 | 5% 210.19K to 220.47K | |
08-Mar-22 7:58 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 04-Mar-22 | Option Sale | 9,325 | $30.61 | $285,425.00 | (4%) 219.51K to 210.19K | |
16-Nov-21 8:40 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 15-Nov-21 | Market Sale | 17,557 | $31.33 | $550,061.00 | (8%) 227.74K to 210.19K | (1%) |
26-May-21 4:11 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 24-May-21 | Payment of Exercise | 5,076 | $19.17 | $97,306.90 | (2%) 232.82K to 227.74K | |
26-May-21 4:11 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 24-May-21 | Option Exercise | 22,633 | $3.76 | $85,100.10 | 11% 210.19K to 232.82K | |
24-Aug-20 4:41 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 20-Aug-20 | Disposition (other) | 45,000 | -- | -- | (18%) 255.19K to 210.19K | |
02-Jun-20 4:50 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 01-Jun-20 | Market Sale | 3,000 | $14.43 | $43,290.00 | (1%) 274.65K to 271.65K | 5% |
02-Jun-20 4:50 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 29-May-20 | Market Sale | 5,000 | $13.99 | $69,950.00 | (2%) 279.65K to 274.65K | 2% |
28-May-20 5:02 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 26-May-20 | Payment of Exercise | 1,108 | $14.90 | $16,509.20 | (< 1%) 280.75K to 279.65K | |
28-May-20 5:02 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 26-May-20 | Option Exercise | 6,172 | $3.56 | $21,972.30 | 2% 274.58K to 280.75K | |
24-Sep-19 6:14 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 20-Sep-19 | Market Sale | 10,395 | $9.51 | $98,856.50 | (4%) 284.98K to 274.58K | 1% |
18-Sep-19 7:06 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 17-Sep-19 | Payment of Exercise | 17,230 | $9.44 | $162,651.00 | (6%) 302.21K to 284.98K | |
18-Sep-19 7:06 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 17-Sep-19 | Option Exercise | 57,612 | $3.53 | $203,381.00 | 24% 244.59K to 302.21K | |
14-Mar-18 4:52 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 12-Mar-18 | Option Exercise | 10,288 | $3.77 | $38,785.80 | 4% 234.31K to 244.59K | |
14-Aug-17 6:06 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 10-Aug-17 | Market Purchase | 6,000 | $2.90 | $17,400.00 | 3% 228.31K to 234.31K | 97% |
02-Aug-16 5:10 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 29-Jul-16 | Payment of Exercise | 4,703 | $7.46 | $35,084.40 | (2%) 233.01K to 228.31K | 28% |
02-Aug-16 5:10 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 29-Jul-16 | Option Exercise | 12,345 | $3.30 | $40,738.50 | 6% 220.66K to 233.01K | |
20-Aug-15 1:11 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 18-Aug-15 | Payment of Exercise | 8,678 | $11.00 | $95,458.00 | (4%) 229.34K to 220.66K | 30% |
20-Aug-15 1:11 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 18-Aug-15 | Option Exercise | 20,576 | $4.94 | $101,594.00 | 10% 208.77K to 229.34K | |
12-Nov-14 10:00 PM View: | Xenon Pharmaceuticals Inc. (XENE) | 09-Nov-14 | Conversion | 2,878 | -- | -- | 2% 189.43K to 192.31K |